Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10609/105186
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorSanches, Clara-
dc.contributor.authorLévy, Richard-
dc.contributor.authorBenisty, Sarah-
dc.contributor.authorVolpe-Gillot, Lisette-
dc.contributor.authorHabert, Marie-Odile-
dc.contributor.authorKas, Aurelie-
dc.contributor.authorStröer, Sébastian-
dc.contributor.authorPyatigorskaya, Nadya-
dc.contributor.authorKaglik, Anna-
dc.contributor.authorBourbon, Angelina-
dc.contributor.authorDubois, Bruno-
dc.contributor.authorMigliaccio, Raffaella-
dc.contributor.authorValero-Cabré, Antoni-
dc.contributor.authorTeichmann, Marc-
dc.contributor.otherUniversitat Oberta de Catalunya (UOC)-
dc.contributor.otherSorbonne Université-
dc.contributor.otherBoston University School of Medicine-
dc.date.accessioned2020-01-10T13:35:38Z-
dc.date.available2020-01-10T13:35:38Z-
dc.date.issued2019-11-20-
dc.identifier.citationSanches, C., Levy, R., Benisty, S., Volpe-Gillot, L., Habert, M.-O., Kas, A., Ströer, S., Pyatigorskaya, N., Kaglik, A., Bourbon, A., Dubois, B., Migliaccio, R., Valero-Cabré, A. & Teichmann, M. (2019). Testing the therapeutic effects of transcranial direct current stimulation (tDCS) in semantic dementia: A double blind, sham controlled, randomized clinical trial. Trials, 20(), -. doi: 10.1186/s13063-019-3613-zen
dc.identifier.issn1745-6215MIAR
-
dc.identifier.urihttp://hdl.handle.net/10609/105186-
dc.description.abstractBackground: Semantic dementia is a neurodegenerative disease that primarily affects the left anterior temporal lobe, resulting in a gradual loss of conceptual knowledge. There is currently no validated treatment. Transcranial stimulation has provided evidence for long-lasting language effects presumably linked to stimulation-induced neuroplasticity in post-stroke aphasia. However, studies evaluating its effects in neurodegenerative diseases such as semantic dementia are still rare and evidence from double-blind, prospective, therapeutic trials is required. Objective: The primary objective of the present clinical trial (STIM-SD) is to evaluate the therapeutic efficacy of a multiday transcranial direct current stimulation (tDCS) regime on language impairment in patients with semantic dementia. The study also explores the time course of potential tDCS-driven improvements and uses imaging biomarkers that could reflect stimulation-induced neuroplasticity. Methods: This is a double-blind, sham-controlled, randomized study using transcranial Direct Current Stimulation (tDCS) applied daily for 10 days, and language/semantic and imaging assessments at four time points: baseline, 3 days, 2 weeks and 4 months after 10 stimulation sessions. Language/semantic assessments will be carried out at these same 4 time points. Fluorodeoxyglucose positron emission tomography (FDG-PET), resting-state functional magnetic resonance imaging (rs-fMRI), T1-weighted images and white matter diffusion tensor imaging (DTI) will be applied at baseline and at the 2-week time point. According to the principle of inter-hemispheric inhibition between left (language-related) and right homotopic regions we will use two stimulation modalities - left-anodal and right-cathodal tDCS over the anterior temporal lobes. Accordingly, the patient population (n = 60) will be subdivided into three subgroups: left-anodal tDCS (n = 20), right-cathodal tDCS (n = 20) and sham tDCS (n = 20). The stimulation will be sustained for 20 min at an intensity of 1.59 mA. It will be delivered through 25cm2-round stimulation electrodes (current density of 0.06 mA/cm2) placed over the left and right anterior temporal lobes for anodal and cathodal stimulation, respectively. A group of healthy participants (n = 20) matched by age, gender and education will also be recruited and tested to provide normative values for the language/semantic tasks and imaging measures. Discussion: The aim of this study is to assess the efficacy of tDCS for language/semantic disorders in semantic dementia. A potential treatment would be easily applicable, inexpensive, and renewable when therapeutic effects disappear due to disease progression.en
dc.language.isoeng-
dc.publisherTrials-
dc.relation.urihttps://trialsjournal.biomedcentral.com/articles/10.1186/s13063-019-3613-z-
dc.rightsCC BY-
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/es/-
dc.subjectNon-invasive brain stimulationen
dc.subjectTranscranial direct current stimulationen
dc.subjectSemantic dementiaen
dc.subjectPrimary progressive aphasiaen
dc.subjectLanguage impairmentsen
dc.subjectNeurodegenerative diseasesen
dc.subjectNeurologyen
dc.titleTesting the therapeutic effects of transcranial direct current stimulation (tDCS) in semantic dementia: a double blind, sham controlled, randomized clinical trial-
dc.typeinfo:eu-repo/semantics/article-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.doi10.1186/s13063-019-3613-z-
dc.gir.idAR/0000007407-
dc.type.versioninfo:eu-repo/semantics/publishedVersion-
Aparece en las colecciones: Articles
Articles cientÍfics

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
Valero-Cabre_Trial_transcranial.pdf3,76 MBAdobe PDFVista previa
Visualizar/Abrir